DNA & Genetics Genmab to Acquire Merus for $8B, Expanding Bispecific Antibody Cancer PipelineBy adminSeptember 30, 20250 Genmab has agreed to acquire Merus for approximately $8 billion, the companies said today, in a deal intended to bolster…
